DSIP Nasal Spray (5mg)
Technische Spezifikationen
| Reinheit (HPLC) | ≥95% (HPLC) |
| CAS-Nummer | 62568-57-4 |
| Form | White lyophilized powder |
| Lagerung | -20°C |
| Sequenz | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu |
| Molekulargewicht | 848.82 g/mol |
| Salzform | Acetate |
| Löslichkeit | Soluble in water |
DSIP Nasal Spray (5mg)
EUR-Listenpreis · HU, SK, CZ, PL
- Eurozone (EUR)130,00 EUR
- Ungarn (HU)130,00 EUR≈ 52 000 Ft
- Slowakei (SK)130,00 EUR
- Tschechien (CZ)130,00 EUR≈ 3 250 Kč
- Polen (PL)130,00 EUR≈ 552,50 zł
Gleicher EUR-Listenpreis für Lieferung nach Ungarn, Slowakei, Tschechien und Polen. Abrechnung in EUR.
HUF/CZK/PLN sind indikativ aus EUR umgerechnet; die Slowakei nutzt EUR. Kurse annähernd. Abrechnung in EUR.
DSIP — Nasenspray 5 mg — intranasale Form von DSIP für Forschung zur nasalen Wirkstoffverabreichung ins ZNS. Nur RUO — ausschließlich für Laborforschung; nicht zum menschlichen Verzehr.
Ausschließlich für Laborforschung.
Nicht für den menschlichen Verzehr, tierärztliche oder diagnostische Zwecke.
From the Peptide Explorer
A nonapeptide first isolated in 1974 from the cerebral venous blood of rabbits during induced slow-wave sleep. DSIP promotes delta-wave (deep) sleep patterns without the sedative effects of GABAergic sleep aids, and has additional roles in stress response and pain modulation.
Key Mechanisms
- ›Delta-wave sleep promotion
- ›Cortisol modulation
- ›LH release modulation
- ›Somatostatin interaction
- ›Endorphin system modulation
Primary Research Areas
- ›Sleep architecture
- ›Insomnia
- ›Stress-related sleep disturbance
- ›Circadian regulation
- ›Pain modulation
Key Research Findings
- Promoted delta-wave sleep in EEG studies without next-day sedation
- Normalized disturbed sleep patterns in chronic insomnia models
- Reduced ACTH and cortisol levels during stress in animal models
Research Overview
A nonapeptide first isolated in 1974 from the cerebral venous blood of rabbits during induced slow-wave sleep. DSIP promotes delta-wave (deep) sleep patterns without the sedative effects of GABAergic sleep aids, and has additional roles in stress response and pain modulation.
Origin: Isolated from cerebral venous blood of rabbits during slow-wave sleep (1974)
Mechanism of Action
- Delta-wave sleep promotion
- Cortisol modulation
- LH release modulation
- Somatostatin interaction
- Endorphin system modulation
Primary Research Areas
- Sleep architecture
- Insomnia
- Stress-related sleep disturbance
- Circadian regulation
- Pain modulation
Key Published Findings
- Promoted delta-wave sleep in EEG studies without next-day sedation
- Normalized disturbed sleep patterns in chronic insomnia models
- Reduced ACTH and cortisol levels during stress in animal models
Research Protocol
Commonly studied routes: Subcutaneous, Intranasal. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
-20°C lyophilized
Important Notice
DSIP Nasal Spray (5mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Forschungsspezifikationen
Synthesized for strict analytical consistency. Verified via HPLC/MS.Qualitätsstandards ansehen →
Handhabung & Lagerung
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water